GILD has put up a solid performance in the past six months on positive data readouts and strong quarterly results. We believe ...

On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $92.41 which represents a slight increase of $1.06 or 1.16% from the prior close of $91.35. The stock opened at ...

According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...

Right now, Gilead Sciences is sporting a Zacks Rank of #2 (Buy), while Vertex Pharmaceuticals has a Zacks Rank of #3 (Hold). Investors should feel comfortable knowing that GILD likely has seen a ...

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene ...

Dr. Reddy’s Laboratories RDY announced that it has launched a biosimilar of Coherus BioSciences’ CHRS Loqtorzi (toripalimab) ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

‘Coordinated psy-op’: Elon Musk echoes Joe Rogan’s defence of Trump Elon Musk defended President-elect Donald Trump, branding criticism against him as a "coordinated psychological operation ...

The head of MI6 says British security will be "jeopardised" if Putin is allowed to succeed in Ukraine, as he warned the spy agency has already uncovered a Russian sabotage campaign in Europe.

#China S. Korea, China hold meeting on stabilizing supply chain SEOUL, Nov. 28 (Yonhap) -- Officials from South Korea and China met Thursday to discuss strategies for maintaining a stable supply chain ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...